Urinary hydroxypyrene determination for biomonitoring of firefighters deployed at the Fort McMurray wildfire: an inter-laboratory method comparison
Urinary 1-hydroxypyrene (OH-Pyr) is widely used for biomonitoring human exposures to polycyclic aromatic hydrocarbons (PAHs) from air pollution and tobacco smoke. However, there have been few rigorous validation studies reported to ensure reliable OH-Pyr determination for occupational health and risk assessment. Herein, we report an inter-laboratory method comparison for urinary OH-Pyr when using gas chromatography-high-resolution mass spectrometry (GC-HRMS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) on urine specimens collected from firefighters (n = 42) deployed at the 2016 Fort McMurray wildfire. Overall, there was good mutual agreement in urinary OH-Pyr quantification following enzyme deconjugation with an average bias of 39% with no significant deviation from linearity (slope = 1.36; p > 0.05), whereas technical precision (< 12%) and average recovery (> 85%) were acceptable when using a stable-isotope internal standard. Faster analysis times (4 min) were achieved by LC-MS/MS without chemical derivatization, whereas lower detection limits (0.64 ng/L, S/N = 3) was realized with solid-phase extraction prior to GC-HRMS. A median creatinine normalized OH-Pyr concentration of 128 ng/g was measured for firefighters that were below the recommended biological exposure index due to delays between early stages of emergency firefighting and urine sample collection. Similar outcomes were also measured for 3-hydroxyphenanthrene and 9-hydroxyfluorene that were positively correlated with urinary OH-Pyr (p < 0.05), implying similar uptake, distribution, and liver biotransformation processes. Optimal specimen collection strategies post-deployment together with standardized protocols for OH-PAH analysis are critical to accurately evaluate smoke exposure in firefighters, including experimental conditions to ensure quantitative enzyme hydrolysis of urine samples.
KeywordsPAHs Firefighters Risk assessment Smoke exposure Urinary biomarkers Fort McMurray
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval was obtained by the Health Ethics Review Board at the University of Alberta prior to sample collection (#Pro000625284).
Informed consent was obtained from all participants included in the study.
- 3.Cherry N, Akililu Y-A, Beach J, Britz-McKibbin P, Elbourne R, Galarneau J-M, et al. Urinary 1-hydroxypyrene and skin contamination in firefighters deployed to the Fort McMurray fire. Ann Work Expo Health. 2019; https://doi.org/10.1093/annweh/wxz006.
- 4.Polycyclic Aromatic Hydrocarbons (PAHs): BEI(R), 7th Edition Documentation, American Conference of Governmental Industrial Hygienists (ACGIH), Cinanatti, OH, USA, 2017;1–25.Google Scholar
- 8.Reports C. Fatalities among volunteer and career firefighters--United States, 1994-2004. MMWR Morb Mortal Wkly Rep. 2006;55:453–5.Google Scholar
- 12.Jongeneelen FJ, Anzion RBM, Scheepers PTJ, Bos RP, Henderson PT, Nijenhuis EH, et al. 1-hydroxypyrene in urine as a biological indicator of exposure to polycyclic aromatic hydrocarbons in several work environments. Ann Occup Hyg. 1988;32:35–43.Google Scholar
- 14.Hansen ÅM, Mathiesen L, Pedersen M, Knudsen LE. Urinary 1-hydroxypyrene (1-HP) in environmental and occupational studies-A review. Int J Hyg Environ Health. 2008;211:471–503.Google Scholar
- 22.Strickland PT, Kang D, Bowman ED, Fitzwilliam A, Downing TE, Rothman N, et al. Identification of 1-hydroxypyrene glucuronide as a major pyrene metabolite in human urine by synchronous fluorescence spectroscopy and gas chromatography-mass spectrometry. Carcinogenesis. 1994;15:483–7.CrossRefGoogle Scholar
- 24.Ramsauer B, Sterz K, Hagedorn H-W, Engl J, Scherer G, McEwan M, et al. A liquid chromatography/tandem mass spectrometry (LC-MS/MS) method for the determination of phenolic polycyclic aromatic hydrocarbons (OH-PAH) in urine of non-smokers and smokers. Anal Bioanal Chem. 2011;399:877–89.CrossRefGoogle Scholar
- 25.Raponi F, Bauleo L, Ancona C, Forastiere F, Paci E, Pigini D, et al. Quantification of 1-hydroxypyrene, 1- and 2-hydroxynaphthalene, 3-hydroxybenzo [a] pyrene and 6-hydroxynitropyrene by HPLC-MS/MS in human urine as exposure biomarkers for environmental and occupational surveys. Biomarkers Taylor & Francis. 2017;22:575–83.Google Scholar
- 26.Campo L, Rossella F, Fustinoni S. Development of a gas chromatography/mass spectrometry method to quantify several urinary monohydroxy metabolites of polycyclic aromatic hydrocarbons in occupationally exposed subjects. J Chromatogr B Anal Technol Biomed Life Sci. 2008;875:531–40.CrossRefGoogle Scholar
- 37.Li Z, Romanoff LC, Trinidad DA, Hussain N, Jones RS, Porter EN, et al. Measurement of urinary monohydroxy polycyclic aromatic hydrocarbons using automated liquid-liquid extraction and gas chromatography/isotope dilution high-resolution mass spectrometry. Anal Chem. 2006;78:5744–51.CrossRefGoogle Scholar
- 42.Strickland P, Kang D, Sithisarankul P. Polycyclic aromatic hydrocarbon metabolites in urine as biomarkers of exposure and effect. Environ Health Perspect. 1996;104:927–32.Google Scholar
- 43.Morgan MS. The biological exposure indices: a key component in protecting workers from toxic chemicals. Environ Health Perspect. 1997;105:105–15.Google Scholar
- 44.Mastrianni KR, Andrew Lee L, Brewer WE, Dongari N, Barna M, Morgan SL. Variations in enzymatic hydrolysis efficiencies for amitriptyline and cyclobenzaprine in urine. J Anal Toxicol. 2016;40:732–7.Google Scholar
- 50.Li Z, Romanoff LC, Lewin MD, Porter EN, Trinidad DA, Needham LL, et al. Variability of urinary concentrations of polycyclic aromatic hydrocarbon metabolite in general population and comparison of spot, first-morning, and 24-h void sampling. J Expo Sci Environ Epidemiol. 2010;20:526–35.CrossRefGoogle Scholar
- 51.Jongeneelen FJ, Van Leeuwen FE, Oosterink S, Anzion RBM. Ambient and biological monitoring of cokeoven workers : determinants of the internal dose of polycyclic aromatic hydrocarbons. Br J Ind Med. 1990;47:454–61.Google Scholar